Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound

被引:263
作者
Gao, ZG
Fain, HD
Rapoport, N
机构
[1] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
[3] Huntsman Canc Inst, Ctr Canc, Salt Lake City, UT 84112 USA
关键词
drug targeting; ultrasound; polymeric micelles; ovarian carcinoma; tumor growth rates;
D O I
10.1016/j.jconrel.2004.09.021
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
The results of a comprehensive in vivo study of a novel tumor-targeting modality are reported. The technique utilized in this study is based on the encapsulation of the chemotherapeutic agent within polymeric micelles in combination with a local ultrasonic irradiation of the tumor. A doxorubicin (DOX) biodistribution, a yield of the internal tumors and a growth rate of the subcutaneous (s.c.) tumors was compared for molecularly dissolved and micellar-encapsulated DOX. This was done with and without tumor sonication, using an ovarian carcinoma tumor model in nu/nu mice. Pure and mixed Pluronic P-105, PEG2000-diacylphospholipid, and poly(ethylene glycol)-co-poly(beta-benzyl-L-aspartate) micelles were used as drug carriers. DOX intracellular uptake was characterized by flow cytometry. A local ultrasonic irradiation of the tumor resulted in a substantially increased drug accumulation in the tumor cells. The effect of the ultrasound was dependent on the time between ultrasound application and drug injection. Ultrasound did not enhance micelle extravasation; the ultrasonic enhancement of drug internalization by the tumor cells required a preliminary passive drug accumulation in the tumor interstitium. Due to the ultrasound-enhanced drug intracellular uptake and cell killing, the yield of intraperitoneal (i.p.) ovarian carcinoma tumors decreased from 70% for DOX dissolved in PBS (positive control) to 36% for the same concentration of DOX encapsulated in Pluronic micelles combined with a 30-s sonication of the abdominal region of a mouse (3 mg/kg DOX, i.p. injection 1 day after inoculation, ngreater than or equal to10). For s.c. tumors, micellar delivery combined with localized ultrasonic tumor irradiation resulted in a substantial decrease of the tumor growth rates compared to a positive control (3 mg/kg DOX, i.v. injections, n=7, p<0.05). Possible mechanisms of the ultrasound bioeffects on in vivo drug targeting are discussed. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:203 / 222
页数:20
相关论文
共 57 条
[1]
Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials [J].
Alakhov, V ;
Klinski, E ;
Li, SM ;
Pietrzynski, G ;
Venne, A ;
Batrakova, E ;
Bronitch, T ;
Kabanov, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :113-134
[2]
Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer [J].
Alakhov, VY ;
Moskaleva, EY ;
Batrakova, EV ;
Kabanov, AV .
BIOCONJUGATE CHEMISTRY, 1996, 7 (02) :209-216
[3]
[Anonymous], DRUD DELIVERY SYST S
[4]
Generation of ultraharmonics in surfactant based ultrasound contrast agents: use and advantages [J].
Basude, R ;
Wheatley, MA .
ULTRASONICS, 2001, 39 (06) :437-444
[5]
Fundamental relationships between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells [J].
Batrakova, E ;
Lee, S ;
Li, S ;
Venne, A ;
Alakhov, V ;
Kabanov, A .
PHARMACEUTICAL RESEARCH, 1999, 16 (09) :1373-1379
[6]
BATRAKOVA EV, 2000, POLYM PREPR, V41, P1739
[7]
In vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound [J].
Bednarski, MD ;
Lee, JW ;
Callstrom, MR ;
Li, KCP .
RADIOLOGY, 1997, 204 (01) :263-268
[8]
Contrast-enhanced US of microcirculation of superficially implanted tumors in rats [J].
Chomas, JE ;
Pollard, RE ;
Sadlowski, AR ;
Griffey, SM ;
Wisner, ER ;
Ferrara, KW .
RADIOLOGY, 2003, 229 (02) :439-446
[9]
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[10]
Ultrasound degradation of novel polymer contrast agents [J].
El-Sherif, DM ;
Lathia, JD ;
Le, NT ;
Wheatley, MA .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2004, 68A (01) :71-78